Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 2:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1273–1296 of 7,893 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Kidney Disease
Interventions: darTreg infusion; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Osteoarthritis of the Knee
Interventions: Cooled Radiofrequency, Standard Radiofrequency; Device
Lead sponsor: Avanos Medical; Other
Eligibility: 21 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 7
States / cities: Altoona, Pennsylvania • Sewickley, Pennsylvania • State College, Pennsylvania + 4 more

Conditions: Phenylketonuria
Interventions: KuvanTM Therapy; Drug
Lead sponsor: Emory University; Other
Eligibility: 4 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Opioid Use, Opioid-Related Disorders
Interventions: Prospective prior authorization (PA) with hard stops in Washington, Retrospective review (RR) with prescriber notification in Ohio; Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 5,411 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Columbus, Ohio • Seattle, Washington

Conditions: Chronic Obstructive Pulmonary Disease (COPD), Smoking, Smoking Cessation, Idiopathic Pulmonary Fibrosis (IPF), Rheumatoid Arthritis-Associated Interstitial Lung Disease, Scleroderma-Associated Interstitial Lung Disease (SSC-ILD)
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: Rehabilitation Intervention; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years and older
Enrollment: 880 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Autism Spectrum Disorder
Interventions: Autism Pupil Screen (APS) Detect PLR Assessment #1, Modified Checklist for Autism in Toddlers, Revised with Follow-up (M-CHAT/R-F), Social Responsiveness Scale, Second Edition (SRS-2), Autism Diagnostic Observation Schedule, Second Edition (ADOS-2), Mullen Scales of Early Learning (MSEL), Adaptive Behavior Assessment System, Third Edition (ABAS-3), Autism Pupil Screen (APS) Detect PLR Assessment #2, Autism Pupil Screen (APS) Detect Assessment #3, Well-child check; Device · Other · Diagnostic Test + 1 more
Lead sponsor: Schweitzer Engineering Laboratories; Industry
Eligibility: 24 Months to 60 Months
Enrollment: 330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Lewiston, Idaho • Moscow, Idaho • Pullman, Washington

Conditions: Pain, Postoperative, Pain, Pain, Acute, Pain, Chronic, Adolescent Behavior, Opioid Use
Interventions: Baseline Survey, Post Operative Surveys, Qualitative Interviews; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 11 Years to 21 Years
Enrollment: 501 participants
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Weight Gain, Obesity
Interventions: GEM, Enhanced Usual Care; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 69 Years
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Depressive Symptoms, Anxiety, Emotional Disorders
Interventions: Living Well; Behavioral
Lead sponsor: University of Texas at Tyler; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Tyler, Texas

Conditions: Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Interventions: larotrectinib(Vitrakvi, BAY2757556); Drug
Lead sponsor: Bayer; Industry
Eligibility: Not listed
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 33
States / cities: Los Angeles, California • Newport Beach, California • Palo Alto, California + 28 more

Conditions: Breast Neoplasms
Interventions: Prayer; Behavioral
Lead sponsor: Southwestern Regional Medical Center; Other
Eligibility: 21 Years to 80 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: End Stage Kidney Disease
Interventions: Standard Table Salt, Salt Substitute; Dietary Supplement
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder
Interventions: Online Pilates exercise; Other
Lead sponsor: Clarkson University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Potsdam, New York

Conditions: Smoking, Sleep Disturbance, Nicotine Dependence
Interventions: Sleep restriction condition, Sleep extension condition; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Urinary Bladder Neoplasms
Interventions: Mitomycin C, Gemcitabine; Drug
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 3
States / cities: Grand Rapids, Michigan

Conditions: Blood Cancer, Bone Marrow Transplant (BMT)
Interventions: exercise intervention; Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Eating Disorders
Interventions: N-back, White Bear Task; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Medication Adherence
Interventions: 5 Behavioral Change Techniques; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Obesity, Adolescent
Interventions: Commercial Advertising Literacy Training, Control; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 8 Years to 12 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Dravet Syndrome
Interventions: Fenfluramine; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 2 Years and older
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: PreDiabetes
Interventions: Registered Dietitian/Nutritionist, Diabetes Prevention Program, Weight Watchers, Reimagined, DPP or RDN Counseling + Medication, Bariatric Surgery Evaluation; Behavioral · Other
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years to 89 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Spinal Muscular Atrophy (SMA)
Interventions: Prospective observational registry, Zolgensma; Other · Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: Not listed
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2038
U.S. locations: 50
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Loma Linda, California + 45 more

Conditions: Healthy Volunteer
Interventions: Tymbion Lidocaine/epinephrine solution, Device: Iontophoresis System (IPS) with Drug: Tymbion lidocaine/epinephrine solution; Drug · Combination Product
Lead sponsor: Tusker Medical; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 2
States / cities: San Jose, California • Bethlehem, Pennsylvania

Search by objective public record fields.

Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )

Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain

Nutritional and Neurotransmitter Changes in PKU Subjects on BH4

Comparing State Payer Strategies to Prevent Unsafe Opioid Prescribing

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction

Effectiveness of the Autism Pupil Screen (APS) Detect Pupillometer for Identifying Autism Spectrum Disorder (ASD) in Routine Healthcare

The Adolescent Surgery Experience: A Mixed Methods Analysis

The GEM (Goals for Eating and Moving) Study

Living Well: A Digital ACT Intervention

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Prayer as a Possible Adjuvant Treatment for Breast Cancer

Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease

Online Pilates Exercise for People With Hypermobility

Racial Differences in Circadian and Sleep Mechanisms for Nicotine Dependence, Craving, and Withdrawal

The Bladder Instillation Comparison Study

Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.

Effects of Cognitive and Emotional Functioning on Treatment Outcomes

Reducing African-American CVD Disparities Intervention Optimization (RADIO) Individuals on Statins

Promoting Resilience to Food Commercials Decreases Susceptibility to Unhealthy Food Decision-Making

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

Preventing Diabetes

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Study to Compare Active Tymbion Iontophoresis to Sham Tymbion Iontophoresis for Anesthesia of the Tympanic Membrane